| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium-dependent cysteine-type endopeptidase activity | 1.45e-11 | 17 | 142 | 7 | GO:0004198 | |
| GeneOntologyMolecularFunction | calcium ion binding | CAPN9 SLC25A24 HSP90B1 CAPN14 VSNL1 SWAP70 FAT3 CAPN1 CAPN2 TRPM2 CAPNS1 PPP2R3B CAPNS2 RCVRN KCNIP3 ZZEF1 RYR2 CAPN8 EFHC2 HPCA MYOF NKD1 USP32 MMP8 HPCAL4 | 1.05e-10 | 749 | 142 | 25 | GO:0005509 |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 1.04e-08 | 86 | 142 | 9 | GO:0004197 | |
| GeneOntologyMolecularFunction | peptidase activity | ATG4A CAPN9 USP34 CAPN14 CAPN1 CAPN2 CAPNS1 CAPNS2 CPA1 ACE CAPN8 ACE2 MMP24 CLCA1 USP32 ADAM17 MMP8 COPS6 MMP16 ENPEP | 4.04e-08 | 654 | 142 | 20 | GO:0008233 |
| GeneOntologyMolecularFunction | endopeptidase activity | ATG4A CAPN9 USP34 CAPN14 CAPN1 CAPN2 CAPNS1 CAPNS2 ACE CAPN8 ACE2 MMP24 CLCA1 ADAM17 MMP8 MMP16 | 7.37e-08 | 430 | 142 | 16 | GO:0004175 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | ATG4A CAPN9 USP34 CAPN14 CAPN1 CAPN2 CAPNS1 CAPNS2 CAPN8 USP32 | 1.18e-06 | 192 | 142 | 10 | GO:0008234 |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.71e-06 | 200 | 142 | 10 | GO:0008237 | |
| GeneOntologyMolecularFunction | glutathione binding | 6.94e-06 | 18 | 142 | 4 | GO:0043295 | |
| GeneOntologyMolecularFunction | metalloexopeptidase activity | 1.05e-05 | 70 | 142 | 6 | GO:0008235 | |
| GeneOntologyMolecularFunction | oligopeptide binding | 1.09e-05 | 20 | 142 | 4 | GO:1900750 | |
| GeneOntologyMolecularFunction | glutathione transferase activity | 5.07e-05 | 29 | 142 | 4 | GO:0004364 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.35e-04 | 37 | 142 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 1.36e-04 | 110 | 142 | 6 | GO:0008238 | |
| GeneOntologyMolecularFunction | peptidyl-dipeptidase activity | 1.50e-04 | 3 | 142 | 2 | GO:0008241 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 2.19e-04 | 120 | 142 | 6 | GO:0004222 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 2.25e-04 | 171 | 142 | 7 | GO:0015103 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.66e-04 | 18 | 142 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC1 HSP90B1 HSP90B2P DYNC2H1 ABCA10 DDX5 ABCA6 ATP13A3 DNAH6 DNAH9 TDRD12 | 3.21e-04 | 441 | 142 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 4.05e-04 | 49 | 142 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC1 HSP90B1 HSP90B2P DYNC2H1 ABCA10 DDX5 ACSL3 MYO3A ABCA6 ATP13A3 DNAH6 DNAH9 TDRD12 | 4.48e-04 | 614 | 142 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCC1 RAN HSP90B1 HSP90B2P DYNC2H1 TRPM2 LRRK2 ABCA10 DDX5 EFTUD2 ABCA6 ATP13A3 DNAH6 DNAH9 TDRD12 | 9.48e-04 | 839 | 142 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCC1 RAN HSP90B1 HSP90B2P DYNC2H1 TRPM2 LRRK2 ABCA10 DDX5 EFTUD2 ABCA6 ATP13A3 DNAH6 DNAH9 TDRD12 | 9.59e-04 | 840 | 142 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCC1 RAN HSP90B1 HSP90B2P DYNC2H1 TRPM2 LRRK2 ABCA10 DDX5 EFTUD2 ABCA6 ATP13A3 DNAH6 DNAH9 TDRD12 | 9.59e-04 | 840 | 142 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.01e-03 | 28 | 142 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | organophosphate:phosphate antiporter activity | 1.03e-03 | 7 | 142 | 2 | GO:0015315 | |
| GeneOntologyMolecularFunction | tumor necrosis factor binding | 1.03e-03 | 7 | 142 | 2 | GO:0043120 | |
| GeneOntologyMolecularFunction | transferase activity, transferring alkyl or aryl (other than methyl) groups | 1.12e-03 | 64 | 142 | 4 | GO:0016765 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCC1 RAN HSP90B1 HSP90B2P DYNC2H1 LRRK2 ABCA10 DDX5 EFTUD2 ABCA6 ATP13A3 DNAH6 DNAH9 TDRD12 | 1.27e-03 | 775 | 142 | 14 | GO:0017111 |
| GeneOntologyMolecularFunction | amide binding | 1.37e-03 | 299 | 142 | 8 | GO:0033218 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 1.50e-03 | 32 | 142 | 3 | GO:0005452 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.56e-03 | 118 | 142 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | metallodipeptidase activity | 2.18e-03 | 10 | 142 | 2 | GO:0070573 | |
| GeneOntologyMolecularFunction | antiporter activity | 3.08e-03 | 138 | 142 | 5 | GO:0015297 | |
| GeneOntologyMolecularFunction | nuclear export signal receptor activity | 3.16e-03 | 12 | 142 | 2 | GO:0005049 | |
| GeneOntologyMolecularFunction | JUN kinase kinase kinase activity | 3.16e-03 | 12 | 142 | 2 | GO:0004706 | |
| GeneOntologyBiologicalProcess | signaling receptor ligand precursor processing | 2.57e-08 | 46 | 141 | 7 | GO:0140448 | |
| GeneOntologyBiologicalProcess | protein processing | ATG4A HSP90B1 HSP90B2P DYNC2H1 CAPN1 CAPN2 LRRK2 BCHE ACE ACE2 ADAM17 MMP16 ENPEP | 8.32e-08 | 285 | 141 | 13 | GO:0016485 |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 1.79e-07 | 37 | 141 | 6 | GO:0042178 | |
| GeneOntologyBiologicalProcess | peptide hormone processing | 3.39e-07 | 41 | 141 | 6 | GO:0016486 | |
| GeneOntologyBiologicalProcess | protein maturation | ATG4A HSP90B1 HSP90B2P DYNC2H1 CAPN1 CAPN2 LRRK2 BCHE ACE AHSA1 TSPAN5 ACE2 ADAM17 MMP16 ENPEP TBCE SORL1 | 1.17e-06 | 619 | 141 | 17 | GO:0051604 |
| GeneOntologyBiologicalProcess | nitrobenzene metabolic process | 1.24e-06 | 4 | 141 | 3 | GO:0018916 | |
| GeneOntologyBiologicalProcess | regulation of phosphatidylcholine biosynthetic process | 3.10e-06 | 5 | 141 | 3 | GO:2001245 | |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 5.08e-06 | 37 | 141 | 5 | GO:0042537 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 5.76e-06 | 141 | 141 | 8 | GO:0006805 | |
| GeneOntologyBiologicalProcess | amide metabolic process | HSP90B1 HSP90B2P BCHE GSAP ACE GSTM1 GSTM2 GSTM4 GSTM5 ACSL3 ACE2 SMPDL3B ENPEP SORL1 | 1.12e-05 | 511 | 141 | 14 | GO:0043603 |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 2.26e-05 | 222 | 141 | 9 | GO:0071466 | |
| GeneOntologyBiologicalProcess | angiotensin maturation | 2.55e-05 | 9 | 141 | 3 | GO:0002003 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | HSP90B1 HSP90B2P BCHE ACE SULT1E1 ACE2 STARD3 UGT2B15 UGT2B17 ENPEP | 2.81e-05 | 286 | 141 | 10 | GO:0042445 |
| GeneOntologyBiologicalProcess | regulation of phosphatidylcholine metabolic process | 3.62e-05 | 10 | 141 | 3 | GO:0150172 | |
| GeneOntologyBiologicalProcess | regulation of gap junction assembly | 3.62e-05 | 10 | 141 | 3 | GO:1903596 | |
| GeneOntologyBiologicalProcess | regulation of angiotensin levels in blood | 4.96e-05 | 11 | 141 | 3 | GO:0002002 | |
| GeneOntologyBiologicalProcess | regulation of ER to Golgi vesicle-mediated transport | 6.58e-05 | 12 | 141 | 3 | GO:0060628 | |
| GeneOntologyBiologicalProcess | positive regulation of phospholipid biosynthetic process | 6.58e-05 | 12 | 141 | 3 | GO:0071073 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | HSP90B1 HSP90B2P VSNL1 TRPM2 BCHE SIN3A ACE SULT1E1 SLC7A8 ACE2 SYTL4 STARD3 UGT2B15 UGT2B17 ENPEP | 7.09e-05 | 684 | 141 | 15 | GO:0010817 |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 1.08e-04 | 14 | 141 | 3 | GO:0071415 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatidylcholine metabolic process | 1.39e-04 | 3 | 141 | 2 | GO:0150173 | |
| GeneOntologyBiologicalProcess | actin rod assembly | 1.39e-04 | 3 | 141 | 2 | GO:0031247 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatidylcholine biosynthetic process | 1.39e-04 | 3 | 141 | 2 | GO:2001247 | |
| GeneOntologyBiologicalProcess | positive regulation of phospholipid metabolic process | 1.64e-04 | 16 | 141 | 3 | GO:1903727 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | ABCC1 HSP90B1 HSP90B2P TRPM2 LRRK2 GRB2 SIN3A ACE CHRNA2 RYR2 MAP3K5 GSTM2 HPCA NAMPT SORL1 | 2.01e-04 | 752 | 141 | 15 | GO:1901699 |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | ABCC1 BCHE ACE EFTUD2 GSTM1 GSTM2 GSTM4 GSTM5 CNTNAP2 UGT2B15 UGT2B17 ADAM17 | 2.66e-04 | 525 | 141 | 12 | GO:0009410 |
| GeneOntologyBiologicalProcess | gap junction assembly | 2.80e-04 | 19 | 141 | 3 | GO:0016264 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid import into cell | 3.27e-04 | 20 | 141 | 3 | GO:0044539 | |
| GeneOntologyBiologicalProcess | regulation of phospholipid biosynthetic process | 3.80e-04 | 21 | 141 | 3 | GO:0071071 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | ABCC1 HSP90B1 HSP90B2P CAPN1 TRPM2 LRRK2 GRB2 BCHE SIN3A ACE CHRNA2 RYR2 MAP3K5 EFTUD2 GSTM1 GSTM2 HPCA NAMPT CNTNAP2 SORL1 | 4.14e-04 | 1272 | 141 | 20 | GO:1901698 |
| GeneOntologyBiologicalProcess | cellular detoxification of nitrogen compound | 4.58e-04 | 5 | 141 | 2 | GO:0070458 | |
| GeneOntologyBiologicalProcess | detoxification of nitrogen compound | 4.58e-04 | 5 | 141 | 2 | GO:0051410 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by circulatory renin-angiotensin | 5.01e-04 | 23 | 141 | 3 | GO:0001991 | |
| GeneOntologyBiologicalProcess | intracellular protein transport | RAN HSP90B1 LRRK2 SPG11 NCOA4 KCNIP3 DDX5 RANBP17 VIPAS39 TRAM1L1 SYTL4 EXOC6B NUP133 SORL1 | 5.58e-04 | 740 | 141 | 14 | GO:0006886 |
| GeneOntologyBiologicalProcess | lysosomal transport | 6.07e-04 | 151 | 141 | 6 | GO:0007041 | |
| GeneOntologyCellularComponent | calpain complex | 2.04e-09 | 4 | 142 | 4 | GO:0110158 | |
| GeneOntologyCellularComponent | caspase complex | 4.15e-07 | 10 | 142 | 4 | GO:0008303 | |
| GeneOntologyCellularComponent | nuclear envelope | RAN CBX3 BCHE RYR2 SULT1E1 RANBP17 MYOF SYNE2 TMX4 NUP133 UGT2B15 UGT2B17 SORL1 | 1.19e-04 | 560 | 142 | 13 | GO:0005635 |
| GeneOntologyCellularComponent | sarcoplasm | 1.29e-04 | 114 | 142 | 6 | GO:0016528 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 3.36e-04 | 88 | 142 | 5 | GO:0016529 | |
| GeneOntologyCellularComponent | intercellular bridge | 4.56e-04 | 94 | 142 | 5 | GO:0045171 | |
| GeneOntologyCellularComponent | endopeptidase complex | 6.62e-04 | 102 | 142 | 5 | GO:1905369 | |
| Domain | EF_hand_dom | CAPN9 SLC25A24 CAPN14 VSNL1 SWAP70 CAPN1 CAPN2 CAPNS1 PPP2R3B CAPNS2 RCVRN KCNIP3 ZZEF1 RYR2 CAPN8 EFHC2 HPCA NKD1 USP32 HPCAL4 | 7.44e-16 | 232 | 140 | 20 | IPR002048 |
| Domain | EF-hand-dom_pair | CAPN9 SLC25A24 CAPN14 VSNL1 SWAP70 SPEF2 CAPN1 CAPN2 CAPNS1 PPP2R3B CAPNS2 RCVRN KCNIP3 ZZEF1 RYR2 CAPN8 EFHC2 HPCA NKD1 USP32 HPCAL4 | 3.65e-15 | 287 | 140 | 21 | IPR011992 |
| Domain | EF_HAND_2 | CAPN9 SLC25A24 CAPN14 VSNL1 CAPN1 CAPN2 CAPNS1 PPP2R3B CAPNS2 RCVRN KCNIP3 ZZEF1 RYR2 CAPN8 EFHC2 HPCA NKD1 USP32 HPCAL4 | 9.82e-15 | 231 | 140 | 19 | PS50222 |
| Domain | - | CAPN9 SLC25A24 CAPN14 VSNL1 CAPN1 CAPN2 CAPNS1 PPP2R3B CAPNS2 RCVRN KCNIP3 ZZEF1 RYR2 CAPN8 EFHC2 HPCA NKD1 USP32 HPCAL4 | 9.07e-14 | 261 | 140 | 19 | 1.10.238.10 |
| Domain | EF_HAND_1 | CAPN9 SLC25A24 CAPN14 VSNL1 CAPN1 CAPN2 CAPNS1 PPP2R3B CAPNS2 RCVRN KCNIP3 CAPN8 HPCA NKD1 USP32 HPCAL4 | 2.96e-12 | 204 | 140 | 16 | PS00018 |
| Domain | EF_Hand_1_Ca_BS | CAPN9 SLC25A24 CAPN14 VSNL1 CAPN1 CAPN2 CAPNS1 PPP2R3B RCVRN KCNIP3 CAPN8 HPCA NKD1 USP32 HPCAL4 | 4.07e-12 | 175 | 140 | 15 | IPR018247 |
| Domain | EFh | CAPN9 SLC25A24 VSNL1 CAPN1 CAPN2 CAPNS1 RCVRN KCNIP3 ZZEF1 RYR2 CAPN8 HPCA USP32 HPCAL4 | 1.40e-11 | 158 | 140 | 14 | SM00054 |
| Domain | EF-hand_8 | 1.25e-10 | 34 | 140 | 8 | PF13833 | |
| Domain | EF-hand_1 | CAPN9 VSNL1 CAPN1 CAPN2 CAPNS1 CAPNS2 RCVRN KCNIP3 RYR2 EFHC2 HPCA HPCAL4 | 1.62e-09 | 152 | 140 | 12 | PF00036 |
| Domain | GST_mu | 1.50e-08 | 5 | 140 | 4 | IPR003081 | |
| Domain | calpain_III | 1.67e-08 | 12 | 140 | 5 | SM00720 | |
| Domain | C2_III | 1.67e-08 | 12 | 140 | 5 | IPR033883 | |
| Domain | Calpain_III | 1.67e-08 | 12 | 140 | 5 | IPR022683 | |
| Domain | Calpain_III | 2.70e-08 | 13 | 140 | 5 | PF01067 | |
| Domain | Calpain_domain_III | 2.70e-08 | 13 | 140 | 5 | IPR022682 | |
| Domain | Calpain_cysteine_protease | 4.18e-08 | 14 | 140 | 5 | IPR022684 | |
| Domain | Peptidase_C2 | 6.23e-08 | 15 | 140 | 5 | PF00648 | |
| Domain | CysPc | 6.23e-08 | 15 | 140 | 5 | SM00230 | |
| Domain | Peptidase_C2_calpain_cat | 6.23e-08 | 15 | 140 | 5 | IPR001300 | |
| Domain | CALPAIN_CAT | 6.23e-08 | 15 | 140 | 5 | PS50203 | |
| Domain | THIOL_PROTEASE_CYS | 1.28e-06 | 26 | 140 | 5 | PS00139 | |
| Domain | THIOL_PROTEASE_ASN | 1.56e-06 | 27 | 140 | 5 | PS00640 | |
| Domain | THIOL_PROTEASE_HIS | 1.56e-06 | 27 | 140 | 5 | PS00639 | |
| Domain | Pept_cys_AS | 1.88e-06 | 28 | 140 | 5 | IPR000169 | |
| Domain | Recoverin | 2.05e-06 | 13 | 140 | 4 | IPR028846 | |
| Domain | EF-hand_7 | 3.47e-06 | 85 | 140 | 7 | PF13499 | |
| Domain | Hemopexin_CS | 6.67e-06 | 17 | 140 | 4 | IPR018486 | |
| Domain | ZINC_PROTEASE | 8.96e-06 | 98 | 140 | 7 | PS00142 | |
| Domain | GST_N | 1.99e-05 | 22 | 140 | 4 | PF02798 | |
| Domain | GST_NTER | 1.99e-05 | 22 | 140 | 4 | PS50404 | |
| Domain | Hemopexin-like_dom | 2.40e-05 | 23 | 140 | 4 | IPR000585 | |
| Domain | Hemopexin-like_repeat | 2.40e-05 | 23 | 140 | 4 | IPR018487 | |
| Domain | HEMOPEXIN | 2.40e-05 | 23 | 140 | 4 | PS00024 | |
| Domain | - | 2.40e-05 | 23 | 140 | 4 | 2.110.10.10 | |
| Domain | HEMOPEXIN_2 | 2.40e-05 | 23 | 140 | 4 | PS51642 | |
| Domain | HX | 2.40e-05 | 23 | 140 | 4 | SM00120 | |
| Domain | Hemopexin | 2.40e-05 | 23 | 140 | 4 | PF00045 | |
| Domain | GST_C | 3.98e-05 | 26 | 140 | 4 | IPR004046 | |
| Domain | GST_C | 3.98e-05 | 26 | 140 | 4 | PF00043 | |
| Domain | Glutathione_S-Trfase_N | 4.64e-05 | 27 | 140 | 4 | IPR004045 | |
| Domain | Peptidase_M2 | 5.58e-05 | 2 | 140 | 2 | PF01401 | |
| Domain | GST_CTER | 1.18e-04 | 34 | 140 | 4 | PS50405 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.41e-04 | 14 | 140 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.41e-04 | 14 | 140 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.41e-04 | 14 | 140 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.41e-04 | 14 | 140 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.41e-04 | 14 | 140 | 3 | IPR011704 | |
| Domain | MT | 1.41e-04 | 14 | 140 | 3 | PF12777 | |
| Domain | AAA_8 | 1.41e-04 | 14 | 140 | 3 | PF12780 | |
| Domain | AAA_5 | 1.41e-04 | 14 | 140 | 3 | PF07728 | |
| Domain | ChSh | 1.67e-04 | 3 | 140 | 2 | SM00300 | |
| Domain | Chromo_shadow_dom | 1.67e-04 | 3 | 140 | 2 | IPR008251 | |
| Domain | Peptidase_M2 | 1.67e-04 | 3 | 140 | 2 | IPR001548 | |
| Domain | Chromo_shadow | 1.67e-04 | 3 | 140 | 2 | PF01393 | |
| Domain | DHC_fam | 1.76e-04 | 15 | 140 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.76e-04 | 15 | 140 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.76e-04 | 15 | 140 | 3 | IPR004273 | |
| Domain | Glutathione-S-Trfase_C-like | 2.03e-04 | 39 | 140 | 4 | IPR010987 | |
| Domain | - | 2.03e-04 | 39 | 140 | 4 | 1.20.1050.10 | |
| Domain | CYSTEINE_SWITCH | 2.47e-04 | 41 | 140 | 4 | PS00546 | |
| Domain | Pept_M10_metallopeptidase | 2.97e-04 | 43 | 140 | 4 | IPR001818 | |
| Domain | Pept_M10A_stromelysin-type | 3.10e-04 | 18 | 140 | 3 | IPR016293 | |
| Domain | PTCB-BRCT | 3.31e-04 | 4 | 140 | 2 | PF12738 | |
| Domain | DUF3377 | 3.31e-04 | 4 | 140 | 2 | PF11857 | |
| Domain | Pept_M10A_metallopeptidase_C | 3.31e-04 | 4 | 140 | 2 | IPR021805 | |
| Domain | PG_binding_1 | 4.28e-04 | 20 | 140 | 3 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 4.28e-04 | 20 | 140 | 3 | IPR002477 | |
| Domain | P-loop_NTPase | ABCC1 RAN DYNC2H1 SPEF2 LRRK2 ABCA10 DDX5 EFTUD2 SULT1E1 MYO3A NPHP3 ABCA6 MYO18B DNAH6 DNAH9 TDRD12 | 6.25e-04 | 848 | 140 | 16 | IPR027417 |
| Domain | M10A_MMP | 6.54e-04 | 23 | 140 | 3 | IPR033739 | |
| Domain | Pept_M10A | 6.54e-04 | 23 | 140 | 3 | IPR021190 | |
| Domain | Peptidase_M10 | 7.43e-04 | 24 | 140 | 3 | PF00413 | |
| Domain | AAA | 7.61e-04 | 144 | 140 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 7.61e-04 | 144 | 140 | 6 | IPR003593 | |
| Domain | Peptidase_Metallo | 1.31e-03 | 29 | 140 | 3 | IPR006026 | |
| Domain | ZnMc | 1.31e-03 | 29 | 140 | 3 | SM00235 | |
| Domain | - | ABCC1 RAN DYNC2H1 SPEF2 LRRK2 ABCA10 DDX5 EFTUD2 SULT1E1 NPHP3 ABCA6 DNAH6 DNAH9 TDRD12 | 1.45e-03 | 746 | 140 | 14 | 3.40.50.300 |
| Domain | DHC_N1 | 1.52e-03 | 8 | 140 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.52e-03 | 8 | 140 | 2 | IPR013594 | |
| Domain | - | 2.26e-03 | 122 | 140 | 5 | 3.40.30.10 | |
| Domain | Chromo_dom_subgr | 2.41e-03 | 10 | 140 | 2 | IPR017984 | |
| Domain | GST_C_3 | 2.41e-03 | 10 | 140 | 2 | PF14497 | |
| Domain | Thioredoxin-like_fold | 3.18e-03 | 132 | 140 | 5 | IPR012336 | |
| Domain | - | 3.22e-03 | 81 | 140 | 4 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 3.22e-03 | 81 | 140 | 4 | IPR024079 | |
| Domain | ABC_A | 3.51e-03 | 12 | 140 | 2 | IPR026082 | |
| Domain | Pept_M10A_Zn_BS | 5.49e-03 | 15 | 140 | 2 | IPR021158 | |
| Domain | tRNAsynth_Ia_anticodon-bd | 5.49e-03 | 15 | 140 | 2 | IPR009080 | |
| Domain | ABC_tran | 5.57e-03 | 48 | 140 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 5.57e-03 | 48 | 140 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 5.90e-03 | 49 | 140 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 6.25e-03 | 50 | 140 | 3 | IPR003439 | |
| Domain | TPR_2 | 6.25e-03 | 50 | 140 | 3 | PF07719 | |
| Domain | TPR_2 | 6.25e-03 | 50 | 140 | 3 | IPR013105 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | CAPN9 CAPN14 CAPN1 CAPN2 CAPNS1 CAPNS2 CAPN8 MMP24 ADAM17 MMP8 MMP16 | 1.15e-08 | 140 | 110 | 11 | M587 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.52e-07 | 114 | 110 | 9 | MM14571 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 5.21e-07 | 39 | 110 | 6 | MM15695 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS | 1.24e-05 | 19 | 110 | 4 | M47809 | |
| Pathway | BIOCARTA_MCALPAIN_PATHWAY | 1.24e-05 | 19 | 110 | 4 | M8719 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.72e-05 | 70 | 110 | 6 | M16794 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 2.00e-05 | 107 | 110 | 7 | MM14595 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 2.02e-05 | 72 | 110 | 6 | M9257 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | CAPN9 CAPN14 CAPN1 CAPN2 CAPNS1 CAPNS2 CAPN8 MMP24 ADAM17 MMP8 MMP16 | 2.22e-05 | 300 | 110 | 11 | M610 |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 2.25e-05 | 109 | 110 | 7 | M18788 | |
| Pathway | BIOCARTA_P35ALZHEIMERS_PATHWAY | 2.52e-05 | 8 | 110 | 3 | M12718 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY | 2.77e-05 | 23 | 110 | 4 | M47806 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY | 3.31e-05 | 24 | 110 | 4 | M47487 | |
| Pathway | REACTOME_DEFECTIVE_INTRINSIC_PATHWAY_FOR_APOPTOSIS | 3.91e-05 | 25 | 110 | 4 | M42527 | |
| Pathway | REACTOME_DRUG_ADME | 3.97e-05 | 119 | 110 | 7 | MM15692 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 7.17e-05 | 29 | 110 | 4 | M45015 | |
| Pathway | BIOCARTA_INTEGRIN_PATHWAY | 1.36e-04 | 34 | 110 | 4 | M3342 | |
| Pathway | BIOCARTA_UCALPAIN_PATHWAY | 1.58e-04 | 14 | 110 | 3 | M13143 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 1.71e-04 | 36 | 110 | 4 | M1443 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.86e-04 | 258 | 110 | 9 | MM14572 | |
| Pathway | REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS | 1.96e-04 | 15 | 110 | 3 | MM14797 | |
| Pathway | REACTOME_DRUG_ADME | 2.08e-04 | 109 | 110 | 6 | M45012 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 2.11e-04 | 38 | 110 | 4 | MM14600 | |
| Pathway | WP_CILIARY_LANDSCAPE | 2.78e-04 | 215 | 110 | 8 | M39734 | |
| Pathway | KEGG_RENIN_ANGIOTENSIN_SYSTEM | 2.90e-04 | 17 | 110 | 3 | M17636 | |
| Pathway | REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS | 2.90e-04 | 17 | 110 | 3 | M27104 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 3.46e-04 | 18 | 110 | 3 | M5290 | |
| Pathway | BIOCARTA_MCALPAIN_PATHWAY | 4.09e-04 | 19 | 110 | 3 | MM1434 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 5.73e-04 | 183 | 110 | 7 | M39588 | |
| Pathway | KEGG_GLUTATHIONE_METABOLISM | 6.13e-04 | 50 | 110 | 4 | M1840 | |
| Pathway | BIOCARTA_P35ALZHEIMERS_PATHWAY | 8.87e-04 | 6 | 110 | 2 | MM1381 | |
| Pathway | WP_GLUCURONIDATION | 9.38e-04 | 25 | 110 | 3 | MM15820 | |
| Pathway | WP_GLUCURONIDATION | 1.05e-03 | 26 | 110 | 3 | M39404 | |
| Pathway | WP_GLUTATHIONE_METABOLISM | 1.18e-03 | 27 | 110 | 3 | MM15908 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 1.21e-03 | 102 | 110 | 5 | M39577 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 1.21e-03 | 102 | 110 | 5 | MM15830 | |
| Pathway | WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS | 1.24e-03 | 7 | 110 | 2 | M39867 | |
| Pubmed | 1.10e-12 | 5 | 143 | 5 | 17646163 | ||
| Pubmed | Calpain: novel family members, activation, and physiologic function. | 2.74e-10 | 4 | 143 | 4 | 8561910 | |
| Pubmed | 2.74e-10 | 4 | 143 | 4 | 22406107 | ||
| Pubmed | 2.74e-10 | 4 | 143 | 4 | 11516996 | ||
| Pubmed | 1.37e-09 | 5 | 143 | 4 | 18551009 | ||
| Pubmed | 1.37e-09 | 5 | 143 | 4 | 19856098 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | RAN WASL DYNC2H1 CAPN1 CAPN2 LRRK2 GRB2 ACE AHSA1 PGM1 DDX5 FABP3 GSTM2 ACE2 MMP24 MYOF SMPDL3B SERPINB1 ENPEP SORL1 | 7.47e-09 | 1016 | 143 | 20 | 19056867 |
| Pubmed | CAPN9 CAPN14 CAPN1 CAPN2 CARS1 GRB2 PTPRU DDX5 SULT1E1 CAPN8 ACSL3 TGM1 MMP24 MMP8 MMP16 GRAP | 6.23e-08 | 730 | 143 | 16 | 34857952 | |
| Pubmed | Small Extracellular Vesicles Have GST Activity and Ameliorate Senescence-Related Tissue Damage. | 6.81e-08 | 3 | 143 | 3 | 32574561 | |
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 9452477 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 18840650 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 16549767 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 16632474 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 8471052 | ||
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 33251580 | ||
| Pubmed | Calpain-generated natural protein fragments as short-lived substrates of the N-end rule pathway. | 6.81e-08 | 3 | 143 | 3 | 24550490 | |
| Pubmed | 6.81e-08 | 3 | 143 | 3 | 23536090 | ||
| Pubmed | 1.16e-07 | 193 | 143 | 9 | 19343046 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | USP34 RAN HSP90B1 SWAP70 CAPN1 CAPN2 CAPNS1 ETF1 SPC25 CARS1 CBX3 ZZEF1 AHSA1 BABAM2 DDX5 EFTUD2 NAMPT CTR9 PPP4R2 NUP133 COPS6 TBCE | 1.34e-07 | 1455 | 143 | 22 | 22863883 |
| Pubmed | 1.44e-07 | 30 | 143 | 5 | 20200426 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RAN XRN2 SWAP70 RRP1B ZC3H15 CAPN1 CAPN2 ETF1 CBX3 SIN3A PGM1 XAB2 DDX5 EFTUD2 ACSL3 TGM1 MYOF NAMPT SYNE2 SERPINB1 COPS6 | 2.06e-07 | 1367 | 143 | 21 | 32687490 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | SLC25A24 RAN HSP90B1 XRN2 DYNC2H1 CAPN1 CAPNS1 ETF1 CBX3 ZZEF1 ACE DDX5 EFTUD2 GSTM4 MYOF NAMPT | 2.41e-07 | 807 | 143 | 16 | 30575818 |
| Pubmed | 2.71e-07 | 4 | 143 | 3 | 8738748 | ||
| Pubmed | Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13. | 2.71e-07 | 4 | 143 | 3 | 8317488 | |
| Pubmed | p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. | 2.71e-07 | 4 | 143 | 3 | 17292829 | |
| Pubmed | 2.71e-07 | 4 | 143 | 3 | 8373352 | ||
| Pubmed | Four genes for the calpain family locate on four distinct human chromosomes. | 2.71e-07 | 4 | 143 | 3 | 2209092 | |
| Pubmed | Variation in the GST mu locus and tobacco smoke exposure as determinants of childhood lung function. | 2.71e-07 | 4 | 143 | 3 | 19151192 | |
| Pubmed | 6.77e-07 | 5 | 143 | 3 | 10825211 | ||
| Pubmed | Calpain translocation during muscle fiber necrosis and regeneration in dystrophin-deficient mice. | 6.77e-07 | 5 | 143 | 3 | 8806430 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SLC25A24 RAN HSP90B1 XRN2 RRP1B ZC3H15 CAPN1 CAPNS1 ETF1 CBX3 AHSA1 XAB2 DDX5 EFTUD2 GSTM1 GSTM2 MYOF NUP133 CBX1 | 1.05e-06 | 1257 | 143 | 19 | 36526897 |
| Pubmed | 1.35e-06 | 6 | 143 | 3 | 22318730 | ||
| Pubmed | 1.35e-06 | 6 | 143 | 3 | 1530570 | ||
| Pubmed | Association of the calpain/calpastatin network with subcellular organelles. | 1.35e-06 | 6 | 143 | 3 | 14559243 | |
| Pubmed | 2.35e-06 | 7 | 143 | 3 | 22615490 | ||
| Pubmed | 2.35e-06 | 7 | 143 | 3 | 20962236 | ||
| Pubmed | 2.35e-06 | 7 | 143 | 3 | 9396712 | ||
| Pubmed | 3.75e-06 | 8 | 143 | 3 | 9473662 | ||
| Pubmed | 3.75e-06 | 8 | 143 | 3 | 20142249 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RAN HSP90B1 RRP1B ZC3H15 CAPN2 CAPNS1 ETF1 SPC25 CARS1 GRB2 CBX3 SIN3A XAB2 DDX5 EFTUD2 NAMPT CTR9 SYNE2 SERPINB1 | 5.87e-06 | 1415 | 143 | 19 | 28515276 |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | HSP90B1 XRN2 RRP1B ZC3H15 ETF1 AHSA1 PGM1 DDX5 VIPAS39 NAMPT SMPDL3B RARS2 TBCE | 7.39e-06 | 704 | 143 | 13 | 32994395 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RAN HSP90B1 ZC3H15 ETF1 CBX3 SIN3A AHSA1 XAB2 DDX5 EFTUD2 NAMPT NUP133 CBX1 MAPRE2 HERC5 | 7.65e-06 | 934 | 143 | 15 | 33916271 |
| Pubmed | 8.47e-06 | 115 | 143 | 6 | 20485444 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | XRN2 RRP1B DYNC2H1 CAPNS1 DDX5 EFTUD2 EFHC2 ACSL3 ZNF836 NPHP3 CTR9 PPP4R2 EXOC6B NUP133 COPS6 MAPRE2 TBCE SORL1 | 8.65e-06 | 1321 | 143 | 18 | 27173435 |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 1.10e-05 | 182 | 143 | 7 | 30711629 | |
| Pubmed | Vital role of the calpain-calpastatin system for placental-integrity-dependent embryonic survival. | 1.46e-05 | 12 | 143 | 3 | 21791606 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 2689439 | ||
| Pubmed | Myocardial infarction increases ACE2 expression in rat and humans. | 1.68e-05 | 2 | 143 | 2 | 15671045 | |
| Pubmed | Essential role of the molecular chaperone gp96 in regulating melanogenesis. | 1.68e-05 | 2 | 143 | 2 | 24024552 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 12244140 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 15034032 | ||
| Pubmed | LRRK2 functions as a scaffolding kinase of ASK1-mediated neuronal cell death. | 1.68e-05 | 2 | 143 | 2 | 28888991 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 10839811 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 15107540 | ||
| Pubmed | [Expression of calpain 1 and calpain 2 during the skin incised wound healing in mice]. | 1.68e-05 | 2 | 143 | 2 | 17619446 | |
| Pubmed | Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. | 1.68e-05 | 2 | 143 | 2 | 12459472 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 16166094 | ||
| Pubmed | Calpain 1 and 2 are required for RNA replication of echovirus 1. | 1.68e-05 | 2 | 143 | 2 | 18032503 | |
| Pubmed | Structure of human glutathione S-transferase class Mu genes. | 1.68e-05 | 2 | 143 | 2 | 2006920 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 21358806 | ||
| Pubmed | Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse. | 1.68e-05 | 2 | 143 | 2 | 28273875 | |
| Pubmed | Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections. | 1.68e-05 | 2 | 143 | 2 | 24800825 | |
| Pubmed | Calpain-2 participates in the process of calpain-1 inactivation. | 1.68e-05 | 2 | 143 | 2 | 33078830 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 32660355 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 23740953 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 3174634 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 18356559 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 34449302 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 31430320 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 31672631 | ||
| Pubmed | Cloning of m-calpain 80 kD subunit from the axonal degeneration-resistant WLD(S) mouse mutant. | 1.68e-05 | 2 | 143 | 2 | 9669314 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 32669323 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 23859598 | ||
| Pubmed | Affinity purification of human m-calpain through an intrinsically disordered inhibitor, calpastatin. | 1.68e-05 | 2 | 143 | 2 | 28319173 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 18490652 | ||
| Pubmed | Vitamin D₃ regulation of body fat, cytokines, and calpain gene expression. | 1.68e-05 | 2 | 143 | 2 | 25520983 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 25869724 | ||
| Pubmed | Angiotensin-converting enzyme 2 is an essential regulator of heart function. | 1.68e-05 | 2 | 143 | 2 | 12075344 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 26396174 | ||
| Pubmed | Type 2 dendritic cells mediate control of cytotoxic T cell resistant tumors. | 1.68e-05 | 2 | 143 | 2 | 34283809 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 15590481 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 11739487 | ||
| Pubmed | 5'-structural analysis of genes encoding polymorphic antigens of chemically induced tumors. | 1.68e-05 | 2 | 143 | 2 | 2438686 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 31358658 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 17671676 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 1909870 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 19136547 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 24048194 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 15471877 | ||
| Pubmed | m-Calpain is required for preimplantation embryonic development in mice. | 1.68e-05 | 2 | 143 | 2 | 16433929 | |
| Pubmed | GRP94 Is Involved in the Lipid Phenotype of Brain Metastatic Cells. | 1.68e-05 | 2 | 143 | 2 | 31395819 | |
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 24121496 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 12461080 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 33973994 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 19004932 | ||
| Pubmed | 1.68e-05 | 2 | 143 | 2 | 8909248 | ||
| Pubmed | Calpain expression in the brain cortex after traumatic brain injury. | 1.68e-05 | 2 | 143 | 2 | 23390828 | |
| Pubmed | DNA methylation is associated with altered gene expression in AMD. | 1.68e-05 | 2 | 143 | 2 | 22410570 | |
| Pubmed | Deletion of muscle GRP94 impairs both muscle and body growth by inhibiting local IGF production. | 1.68e-05 | 2 | 143 | 2 | 22649033 | |
| Pubmed | Calpains are required for invasive and metastatic potentials of human HCC cells. | 1.68e-05 | 2 | 143 | 2 | 23733271 | |
| Interaction | GSTM3 interactions | 8.34e-07 | 148 | 138 | 9 | int:GSTM3 | |
| Interaction | CAPN3 interactions | 1.82e-06 | 54 | 138 | 6 | int:CAPN3 | |
| Interaction | GSTM5 interactions | 2.71e-06 | 15 | 138 | 4 | int:GSTM5 | |
| Interaction | GSTM1 interactions | 2.71e-06 | 15 | 138 | 4 | int:GSTM1 | |
| Interaction | CAPN11 interactions | 3.59e-06 | 16 | 138 | 4 | int:CAPN11 | |
| Interaction | GSTM2 interactions | 1.40e-05 | 22 | 138 | 4 | int:GSTM2 | |
| Interaction | CAPN2 interactions | 2.18e-05 | 169 | 138 | 8 | int:CAPN2 | |
| Interaction | MMP20 interactions | 3.64e-05 | 10 | 138 | 3 | int:MMP20 | |
| Interaction | MMP27 interactions | 4.98e-05 | 11 | 138 | 3 | int:MMP27 | |
| Interaction | MMP11 interactions | 6.61e-05 | 12 | 138 | 3 | int:MMP11 | |
| Interaction | DERL1 interactions | ABCC1 HSP90B1 FRAS1 USE1 DDX5 SLC7A8 ACSL3 LMBR1L SYNE2 TMX4 NUP133 ADAM17 | 6.80e-05 | 453 | 138 | 12 | int:DERL1 |
| Interaction | AGR2 interactions | SLC25A24 RAN HSP90B1 XRN2 NRAP DYNC2H1 CAPN1 CAPNS1 ETF1 GRB2 CBX3 ZZEF1 ACE DDX5 EFTUD2 GSTM4 MYOF NAMPT | 7.02e-05 | 934 | 138 | 18 | int:AGR2 |
| Interaction | ABI3BP interactions | 8.54e-05 | 13 | 138 | 3 | int:ABI3BP | |
| Interaction | OGT interactions | RAN HSP90B1 XRN2 RRP1B ZC3H15 ETF1 SIN3A AHSA1 PGM1 DDX5 EFTUD2 VIPAS39 NAMPT NPHP3 SMPDL3B RARS2 TRAK2 TBCE | 8.71e-05 | 950 | 138 | 18 | int:OGT |
| Cytoband | 1p13.3 | 2.62e-06 | 69 | 143 | 5 | 1p13.3 | |
| GeneFamily | EF-hand domain containing | CAPN9 SLC25A24 CAPN14 VSNL1 SWAP70 CAPN1 CAPN2 CAPNS1 PPP2R3B CAPNS2 RCVRN KCNIP3 ZZEF1 RYR2 CAPN8 EFHC2 HPCA NKD1 USP32 HPCAL4 | 1.00e-18 | 219 | 104 | 20 | 863 |
| GeneFamily | C2 domain containing|Calpains | 1.64e-08 | 15 | 104 | 5 | 975 | |
| GeneFamily | Glutathione S-transferases | 1.19e-05 | 25 | 104 | 4 | 567 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 3.43e-04 | 24 | 104 | 3 | 891 | |
| GeneFamily | Chromobox family | 8.97e-04 | 8 | 104 | 2 | 976 | |
| GeneFamily | ATP binding cassette subfamily A | 2.85e-03 | 14 | 104 | 2 | 805 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 3.15e-03 | 51 | 104 | 3 | 870 | |
| GeneFamily | Dyneins, axonemal | 4.21e-03 | 17 | 104 | 2 | 536 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class I | 5.26e-03 | 19 | 104 | 2 | 131 | |
| Coexpression | GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_DN | 7.99e-07 | 136 | 142 | 8 | M41157 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 SLC25A24 USP34 ABCC1 SWAP70 SPC25 TOPBP1 SPG11 ZZEF1 TSPAN5 ACSL3 MYOF NAMPT SYNE2 NUP133 ADAM17 ATP13A3 | 4.13e-06 | 856 | 142 | 17 | M4500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | CFH DOCK4 VSNL1 FAT3 BCHE TSPAN5 RYR2 GSTM1 GSTM2 ACE2 MYOF CLCA1 TENM4 SMPDL3B NKD1 SYTL4 SERPINB1 ATP13A3 | 1.68e-06 | 740 | 139 | 18 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | CFH SLC25A24 VSNL1 FAT3 CPA1 ANGPTL1 TSPAN5 GSTM1 GSTM2 SLC7A8 ACE2 MYOF CLCA1 TENM4 SYNE2 SERPINB1 MMP16 ENPEP | 3.10e-06 | 773 | 139 | 18 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | CFH DOCK4 VSNL1 DYNC2H1 FAT3 CPA1 TSPAN5 RYR2 GSTM2 ACE2 MYOF CLCA1 TENM4 SMPDL3B NKD1 SYNE2 SERPINB1 ATP13A3 | 3.70e-06 | 783 | 139 | 18 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 5.43e-06 | 146 | 139 | 8 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#2_top-relative-expression-ranked_500 | 6.93e-06 | 41 | 139 | 5 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k2_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | DOCK4 SLC25A24 CASP8AP2 GLDN FAT3 CPA1 TSPAN5 GSTM1 GSTM2 GSTM4 ACE2 MYOF CLCA1 TENM4 NKD1 SYNE2 TMX4 MMP16 | 7.85e-06 | 827 | 139 | 18 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | CFH DOCK4 VSNL1 TSPAN5 RYR2 GSTM2 ACE2 MYOF CLCA1 TENM4 SMPDL3B NKD1 | 9.69e-06 | 388 | 139 | 12 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | CFH GLDN VSNL1 FAT3 SPC25 CPA1 ANGPTL1 TSPAN5 GSTM1 GSTM2 ACE2 MYOF CLCA1 TENM4 SYNE2 SERPINB1 ENPEP | 1.15e-05 | 768 | 139 | 17 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.Bl, Cd115+ B220- CD43+ Ly6C+ MHCII-, Blood, avg-3 | CFH DOCK4 LRRK2 GSAP ACE GSTM1 SLC7A8 MYOF SMPDL3B ABCA6 MMP8 SORL1 | 1.72e-05 | 411 | 139 | 12 | GSM605872_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | DOCK4 VSNL1 FAT3 CPA1 BCHE TSPAN5 RYR2 FABP3 GSTM2 ACE2 MYOF CLCA1 TENM4 SMPDL3B NKD1 SYTL4 SERPINB1 | 1.85e-05 | 797 | 139 | 17 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | DOCK4 GLDN FAT3 CPA1 TSPAN5 GSTM2 GSTM4 ACE2 MYOF CLCA1 TENM4 NKD1 | 2.03e-05 | 418 | 139 | 12 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | CFH VSNL1 FAT3 CPA1 GSTM1 GSTM2 ACE2 MYOF CLCA1 SERPINB1 ENPEP | 2.33e-05 | 356 | 139 | 11 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | CFH DOCK4 VSNL1 BCHE RYR2 GSTM2 ACE2 CLCA1 SMPDL3B NKD1 SYTL4 | 2.39e-05 | 357 | 139 | 11 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | GLDN VSNL1 FAT3 GSTM1 GSTM2 ACE2 MYOF CLCA1 TENM4 SERPINB1 ENPEP | 2.85e-05 | 364 | 139 | 11 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_200 | 3.51e-05 | 138 | 139 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_200 | 4.21e-05 | 59 | 139 | 5 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200 | 5.04e-05 | 146 | 139 | 7 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | DOCK4 GLDN VSNL1 FAT3 CPA1 TSPAN5 FABP3 GSTM1 GSTM2 GSTM4 ACE2 MYOF CLCA1 TENM4 SERPINB1 ENPEP | 6.43e-05 | 793 | 139 | 16 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | DOCK4 USP34 VSNL1 USE1 NCOA4 RYR2 GSTM1 GSTM2 EFHC2 CLCA1 TENM4 SMPDL3B SYTL4 SYNE2 SERPINB1 MMP16 | 6.62e-05 | 795 | 139 | 16 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 6.73e-05 | 207 | 139 | 8 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 6.77e-05 | 153 | 139 | 7 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.42e-05 | 107 | 139 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | CFH SLC25A24 FAT3 ACE2 MYOF CLCA1 TENM4 SERPINB1 MMP16 ENPEP | 7.56e-05 | 336 | 139 | 10 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.74e-05 | 337 | 139 | 10 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_100 | 9.82e-05 | 37 | 139 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 1.09e-04 | 165 | 139 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_100 | 1.18e-04 | 73 | 139 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 1.36e-04 | 361 | 139 | 10 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_100 | 1.42e-04 | 76 | 139 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_100 | 1.61e-04 | 78 | 139 | 5 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 1.78e-04 | 373 | 139 | 10 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | CFH DOCK4 USP34 WASL RYR2 GSTM1 GSTM2 EFHC2 TENM4 SMPDL3B SYTL4 SYNE2 TMX4 MMP16 TDRD12 | 1.81e-04 | 778 | 139 | 15 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 2.04e-04 | 82 | 139 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.09e-04 | 310 | 139 | 9 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#4_top-relative-expression-ranked_500 | 2.32e-04 | 46 | 139 | 4 | gudmap_developingGonad_e12.5_epididymis_k4_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_200 | 3.62e-04 | 143 | 139 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.65e-04 | 265 | 139 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | Myeloid Cells, GN.BM, CD11b+ Ly6-G+, Bone marrow, avg-4 | SLC25A24 TRPM2 LRRK2 CAPNS2 SYNE2 TMX4 SERPINB1 MMP8 DNAH6 SORL1 | 4.14e-04 | 415 | 139 | 10 | GSM605846_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 4.19e-04 | 147 | 139 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.35e-04 | 148 | 139 | 6 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k4_1000 | |
| CoexpressionAtlas | Myeloid Cells, MF.Lu, CD11chi CD11b- CD103- MHCII- SiglecF+, Lung, avg-3 | DOCK4 GSAP NCOA4 GSTM1 SLC7A8 MYOF SYNE2 SERPINB1 ATP13A3 MMP8 | 4.99e-04 | 425 | 139 | 10 | GSM538282_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_200 | 5.01e-04 | 152 | 139 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_200 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | CFH USP34 WASL MCPH1 RYR2 MAP3K5 GSTM1 GSTM2 TENM4 SMPDL3B SYTL4 SYNE2 SERPINB1 MMP16 | 5.38e-04 | 770 | 139 | 14 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_500 | 5.67e-04 | 58 | 139 | 4 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_200 | 5.68e-04 | 25 | 139 | 3 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 5.74e-04 | 156 | 139 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | CFH FRAS1 VSNL1 FAT3 CPA1 GSTM2 ACE2 MYOF CLCA1 TENM4 NKD1 SERPINB1 MMP16 ENPEP | 5.88e-04 | 777 | 139 | 14 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_200 | 6.27e-04 | 6 | 139 | 2 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k4_200 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_top-relative-expression-ranked_1000 | ATG4A CFH DOCK4 CAPN2 LRRK2 TSPAN5 MAP3K5 SLC7A8 MYOF NAMPT UGT2B15 SERPINB1 ATP13A3 TRAK2 ENPEP | 6.47e-04 | 878 | 139 | 15 | gudmap_kidney_adult_RenCorpuscGlomer_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_200 | 7.16e-04 | 27 | 139 | 3 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | DOCK4 VSNL1 FAT3 CPA1 TSPAN5 RYR2 GSTM2 ACE2 MYOF CLCA1 TENM4 SMPDL3B NKD1 SYTL4 | 7.53e-04 | 797 | 139 | 14 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.46e-04 | 168 | 139 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | 8.94e-04 | 379 | 139 | 9 | gudmap_developingGonad_P2_ovary_500 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.53e-10 | 199 | 141 | 10 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-08 | 195 | 141 | 9 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-08 | 195 | 141 | 9 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.34e-08 | 196 | 141 | 9 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.46e-08 | 198 | 141 | 9 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-08 | 170 | 141 | 8 | 8e1f757ed62218c0fb6525f49d142dd2cd29acf9 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-08 | 170 | 141 | 8 | 67d7e1da3ebd2d14cb2e67799e94d655027ed5c4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.64e-07 | 189 | 141 | 8 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.01e-07 | 194 | 141 | 8 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.09e-07 | 195 | 141 | 8 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-07 | 197 | 141 | 8 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.53e-07 | 200 | 141 | 8 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.53e-07 | 200 | 141 | 8 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.53e-07 | 200 | 141 | 8 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.91e-07 | 153 | 141 | 7 | d5f5399ebbbff508c96ce7f01272716b61597ab5 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.91e-07 | 153 | 141 | 7 | 32cf4ca828d228f23366480305592f9813fed7ff | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-06 | 169 | 141 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-06 | 181 | 141 | 7 | 65eaa9bc1022bcf0c5f0f92c07a2cbbf11f9b59c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(PRG4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-06 | 181 | 141 | 7 | eaac7d58117eddfff06b25521efc431c1351d592 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.82e-06 | 181 | 141 | 7 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l11|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.10e-06 | 118 | 141 | 6 | a58dc4fcd92adcae5fae364052be4b909797e9f0 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.26e-06 | 187 | 141 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-06 | 191 | 141 | 7 | 6cab0334f76c973880bd8d1638856f2f6e4a249a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-06 | 191 | 141 | 7 | 850c6fff6dc795431ef534fdaa41e4ad50f7367a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-06 | 191 | 141 | 7 | 8b2b00202d3c98bccbae1b4a23713892fad0ff23 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.60e-06 | 191 | 141 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.69e-06 | 192 | 141 | 7 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.69e-06 | 192 | 141 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 2.69e-06 | 192 | 141 | 7 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-MK-early_MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.09e-06 | 196 | 141 | 7 | fc541e328aed28e84d5b3835169c60da0d64cddc | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.19e-06 | 197 | 141 | 7 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.19e-06 | 197 | 141 | 7 | 2744cc94883c5d0424677cf5093bbab622933e9b | |
| ToppCell | PCW_10-12|World / Celltypes from embryonic and fetal-stage human lung | 3.19e-06 | 197 | 141 | 7 | 47fd8b0d596c5db1a722473c8efbb17a6bbe7538 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.19e-06 | 197 | 141 | 7 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | distal-1-mesenchymal-Mesothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.41e-06 | 199 | 141 | 7 | 8dd5b411d2f1626830b77a1616cc3fb67dc59338 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-06 | 199 | 141 | 7 | 103f657132e830a0e5efeb745afb4b77c208a1fa | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 3.41e-06 | 199 | 141 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.41e-06 | 199 | 141 | 7 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.41e-06 | 199 | 141 | 7 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.41e-06 | 199 | 141 | 7 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.41e-06 | 199 | 141 | 7 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.53e-06 | 200 | 141 | 7 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | distal-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.53e-06 | 200 | 141 | 7 | 12b705dabec1b3752a488a891eda1a5123fcdc41 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.53e-06 | 200 | 141 | 7 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.53e-06 | 200 | 141 | 7 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.53e-06 | 200 | 141 | 7 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.53e-06 | 200 | 141 | 7 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-06 | 200 | 141 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.53e-06 | 200 | 141 | 7 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-C_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.39e-06 | 143 | 141 | 6 | b74571d30def54a0524c8d95a3bc9d3439319eb4 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-C_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.39e-06 | 143 | 141 | 6 | 5c81b238be53f010d691d0c59c1c29cb52222ed3 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-05 | 155 | 141 | 6 | e1a20e88b9c0eaf7ca7004acc0eda096d1588563 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 160 | 141 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 160 | 141 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 171 | 141 | 6 | fea6ef6bbfebea2dd0f0360c7db7a5e858f15958 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.77e-05 | 171 | 141 | 6 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 171 | 141 | 6 | f15594fd4d709920733de9376a391dedc62b65de | |
| ToppCell | droplet-Heart-4Chambers-21m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 174 | 141 | 6 | f098778ea74012861ec74b425e45776a31f67679 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 175 | 141 | 6 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 176 | 141 | 6 | b4a23d8d1414434adeb237a96f28c825f1aebd77 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.08e-05 | 176 | 141 | 6 | 450c25ec5eeb65425f904e0a25aaafdf5682ef9c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 176 | 141 | 6 | 66c9c6b59030f67e8d746a9c6930e50923f2ded1 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-05 | 177 | 141 | 6 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.15e-05 | 177 | 141 | 6 | 7af1a19692f7fe8f691178a4e57d62bc379e3d56 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-05 | 177 | 141 | 6 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | LPS-antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.22e-05 | 178 | 141 | 6 | afcc92e8fe313c85eaf617cf4dbc3058da6c99d6 | |
| ToppCell | LPS-antiTNF-Myeloid-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.22e-05 | 178 | 141 | 6 | bd689205bc92cda5f71df64c2332ff76adcd84b4 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.29e-05 | 179 | 141 | 6 | dcd0a83f0592ae27f814d064b4791f84c3c86e64 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.29e-05 | 179 | 141 | 6 | 056df2aaff750e0e283e7da78fcc3c90c366aac0 | |
| ToppCell | LPS_only-Myeloid-Neutrophils|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-05 | 179 | 141 | 6 | d0a03e498afcfeb657037889685ecd77bed07e6c | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.29e-05 | 179 | 141 | 6 | f5f3945ef3b9efc5921a71fd51deeb2c80f0ce11 | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.29e-05 | 179 | 141 | 6 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | LPS_only-Myeloid-Neutrophils-Neutrophils|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-05 | 179 | 141 | 6 | d034651a5a355a58f5e15db627869f4feebdfe35 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-05 | 180 | 141 | 6 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.52e-05 | 182 | 141 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | LPS_only-Myeloid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-05 | 182 | 141 | 6 | 666ac86ee5f6fa9241ae8d80340743707e54b278 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 184 | 141 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.67e-05 | 184 | 141 | 6 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 184 | 141 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 184 | 141 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 2.67e-05 | 184 | 141 | 6 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.76e-05 | 185 | 141 | 6 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 185 | 141 | 6 | 9f6c1e35047d1618974b802a1d609c1f4b99ce84 | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.76e-05 | 185 | 141 | 6 | e8f7da9641b6cf1db1093b4f301ce828fd3a529c | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 185 | 141 | 6 | a82a0252ae091ee8fcb453ae03ba21542b220e8f | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-05 | 187 | 141 | 6 | 59313a47a6012b2413d7d3673bb05fb7e49fd88f | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.93e-05 | 187 | 141 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.02e-05 | 188 | 141 | 6 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | Pericytes-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.02e-05 | 188 | 141 | 6 | 14c1c88a944c66f2eaac1ce7526815dcce1f5147 | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 3.11e-05 | 189 | 141 | 6 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | IPF-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 3.11e-05 | 189 | 141 | 6 | 7a260485c2a7c743c14d048e5e480ae0a9b8e32c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.11e-05 | 189 | 141 | 6 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.11e-05 | 189 | 141 | 6 | 46c5b975fb9d33017f2d9b7770d45a8bdf95baa2 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.11e-05 | 189 | 141 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.20e-05 | 190 | 141 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.20e-05 | 190 | 141 | 6 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 3.20e-05 | 190 | 141 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 190 | 141 | 6 | ad0f5605db6b694445ec9bd5dc8d2d834358c0f9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.20e-05 | 190 | 141 | 6 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 190 | 141 | 6 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| Computational | ROS metabolism. | 4.19e-05 | 22 | 98 | 4 | MODULE_310 | |
| Computational | Genes in the cancer module 101. | 8.42e-05 | 10 | 98 | 3 | MODULE_101 | |
| Computational | Genes in the cancer module 132. | 2.49e-04 | 14 | 98 | 3 | MODULE_132 | |
| Drug | sulfolithocholic acid | 9.46e-07 | 4 | 142 | 3 | ctd:C014202 | |
| Drug | Hoe 065 | 9.46e-07 | 4 | 142 | 3 | CID000197279 | |
| Drug | AC1Q6PMP | 1.19e-06 | 169 | 142 | 9 | CID000103535 | |
| Drug | Dcvg | 1.31e-06 | 31 | 142 | 5 | CID006437359 | |
| Drug | oltipraz | 2.38e-06 | 137 | 142 | 8 | CID000047318 | |
| Drug | EUK-189 | 2.49e-06 | 16 | 142 | 4 | ctd:C436526 | |
| Drug | Clch2cosg | 4.15e-06 | 18 | 142 | 4 | CID000163913 | |
| Drug | C14791 | 4.15e-06 | 18 | 142 | 4 | CID011954044 | |
| Drug | C14793 | 4.15e-06 | 18 | 142 | 4 | CID011954046 | |
| Drug | C14803 | 4.15e-06 | 18 | 142 | 4 | CID011954054 | |
| Drug | C14805 | 4.15e-06 | 18 | 142 | 4 | CID011954056 | |
| Drug | C14804 | 4.15e-06 | 18 | 142 | 4 | CID011954055 | |
| Drug | C14806 | 4.15e-06 | 18 | 142 | 4 | CID011954057 | |
| Drug | C14848 | 4.15e-06 | 18 | 142 | 4 | CID011954067 | |
| Drug | C14856 | 4.15e-06 | 18 | 142 | 4 | CID011954069 | |
| Drug | C14855 | 4.15e-06 | 18 | 142 | 4 | CID011954068 | |
| Drug | S-(2,2-dichloro-1-hydroxy)ethylglutathione | 4.15e-06 | 18 | 142 | 4 | CID011954070 | |
| Drug | AC1L4MYY | 4.15e-06 | 18 | 142 | 4 | CID000188517 | |
| Drug | MMI270 | 4.15e-06 | 18 | 142 | 4 | CID000446504 | |
| Drug | 1-chloro-2,4-dinitrobenzene-glutathione conjugate | 4.69e-06 | 6 | 142 | 3 | ctd:C042630 | |
| Drug | beta-naphthoflavone | 4.75e-06 | 200 | 142 | 9 | CID000002361 | |
| Drug | CAS 87-33-2 | 6.39e-06 | 73 | 142 | 6 | CID000003780 | |
| Drug | 2-(S-glutathionyl) acetyl glutathione | 6.50e-06 | 20 | 142 | 4 | CID011954072 | |
| Drug | C14865 | 6.50e-06 | 20 | 142 | 4 | CID011954073 | |
| Drug | HOCl | 1.13e-05 | 169 | 142 | 8 | CID000024341 | |
| Drug | Boc-ca-phe | 1.30e-05 | 8 | 142 | 3 | CID005487215 | |
| Drug | Z-ca-gly-phe | 1.30e-05 | 8 | 142 | 3 | CID000195338 | |
| Drug | CHEBI:38548 | 1.30e-05 | 8 | 142 | 3 | CID016126809 | |
| Drug | oxidized glutathione | 1.32e-05 | 227 | 142 | 9 | CID000000975 | |
| Drug | S-(formylmethyl)glutathione | 1.40e-05 | 24 | 142 | 4 | CID011954074 | |
| Drug | DB04618 | 1.64e-05 | 51 | 142 | 5 | CID004369393 | |
| Drug | CID5192997 | 1.88e-05 | 88 | 142 | 6 | CID005192996 | |
| Drug | hippuryl-histidyl-leucine | 1.95e-05 | 26 | 142 | 4 | CID000094418 | |
| Drug | Pro-leu-gly | 1.95e-05 | 26 | 142 | 4 | CID000169533 | |
| Drug | 1-(2-trifluoromethoxyphenyl)-2-nitroethanone | 2.08e-05 | 184 | 142 | 8 | ctd:C576882 | |
| Drug | zinc chloride (ZnCl2 | 2.25e-05 | 186 | 142 | 8 | CID000005727 | |
| Drug | S-hexylglutathione | 2.38e-05 | 55 | 142 | 5 | CID000005140 | |
| Drug | DNCB | 2.53e-05 | 189 | 142 | 8 | CID000000006 | |
| Drug | AC1Q608X | 2.64e-05 | 28 | 142 | 4 | CID000128466 | |
| Drug | AC1L33DC | 2.64e-05 | 28 | 142 | 4 | CID000133757 | |
| Drug | AC1O5VRZ | 2.76e-05 | 10 | 142 | 3 | CID006441686 | |
| Drug | AC1L3C7Z | 2.76e-05 | 10 | 142 | 3 | CID000086747 | |
| Drug | 8-Bromo Cyclic Adenosine Monophosphate | ABCC1 RAN FRAS1 CAPN2 CARS1 ANGPTL1 GSTM2 GSTM4 ACE2 HPCA MYOF TMX4 STARD3 UGT2B17 MMP16 | 2.94e-05 | 693 | 142 | 15 | ctd:D015124 |
| Drug | NSC9567 | 2.98e-05 | 141 | 142 | 7 | CID000003001 | |
| Drug | 2-BHA | 3.05e-05 | 29 | 142 | 4 | CID000006932 | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Up 200; 11.8uM; PC3; HT_HG-U133A | 3.40e-05 | 197 | 142 | 8 | 6619_UP | |
| Drug | Conessine [546-06-5]; Up 200; 11.2uM; HL60; HT_HG-U133A | 3.40e-05 | 197 | 142 | 8 | 2135_UP | |
| Drug | Alprostadil [745-65-3]; Down 200; 11.2uM; PC3; HT_HG-U133A | 3.52e-05 | 198 | 142 | 8 | 4099_DN | |
| Drug | Dns-gltaptv | 3.78e-05 | 11 | 142 | 3 | CID005487274 | |
| Drug | bradykinin potentiator c | 3.86e-05 | 2 | 142 | 2 | CID004597608 | |
| Drug | isomartynoside | 3.86e-05 | 2 | 142 | 2 | CID006476337 | |
| Drug | 2-nitrophenyl diethyl phosphate | 3.86e-05 | 2 | 142 | 2 | CID003014292 | |
| Drug | dansyltriglycine | 3.86e-05 | 2 | 142 | 2 | CID000194208 | |
| Drug | EU-4881 | 3.86e-05 | 2 | 142 | 2 | CID000146389 | |
| Drug | Glutathione S-(2,4 Dinitrobenzene) | 3.86e-05 | 2 | 142 | 2 | DB02458 | |
| Drug | A58365B | 3.86e-05 | 2 | 142 | 2 | CID000137366 | |
| Drug | A58365A | 3.86e-05 | 2 | 142 | 2 | CID000137365 | |
| Drug | AC1NNL9J | 3.86e-05 | 2 | 142 | 2 | CID005046512 | |
| Drug | I5b2 | 3.86e-05 | 2 | 142 | 2 | CID000125070 | |
| Drug | Lisinopril | 3.86e-05 | 2 | 142 | 2 | DB00722 | |
| Drug | Moexipril | 3.86e-05 | 2 | 142 | 2 | DB00691 | |
| Drug | Ahtp-BK | 3.86e-05 | 2 | 142 | 2 | CID000128372 | |
| Drug | tebanyl | 3.86e-05 | 2 | 142 | 2 | CID000008609 | |
| Drug | CV-5975 | 3.86e-05 | 2 | 142 | 2 | CID003035825 | |
| Drug | EU-4865 | 3.86e-05 | 2 | 142 | 2 | CID000132472 | |
| Drug | MDL 27,788 | 3.86e-05 | 2 | 142 | 2 | CID005748412 | |
| Drug | EU-5031 | 3.86e-05 | 2 | 142 | 2 | CID000194686 | |
| Drug | BRL 36378 | 3.86e-05 | 2 | 142 | 2 | CID000134835 | |
| Drug | chlorambucyl-proline | 3.86e-05 | 2 | 142 | 2 | CID000133596 | |
| Drug | DU-1227 | 3.86e-05 | 2 | 142 | 2 | CID000156284 | |
| Drug | Ketoace | 3.86e-05 | 2 | 142 | 2 | CID000156271 | |
| Drug | MDL27,467A | 3.86e-05 | 2 | 142 | 2 | CID000194915 | |
| Drug | Phenothiazines | 3.86e-05 | 2 | 142 | 2 | ctd:D010640 | |
| Drug | PenCB | 3.95e-05 | 61 | 142 | 5 | CID000036188 | |
| Drug | o-dinitrobenzene | 4.00e-05 | 31 | 142 | 4 | CID000010707 | |
| Drug | Spironolactone | 4.61e-05 | 103 | 142 | 6 | ctd:D013148 | |
| Drug | 1,10-phenanthroline | 4.71e-05 | 267 | 142 | 9 | CID000001318 | |
| Drug | SNJ-1945 | 5.01e-05 | 12 | 142 | 3 | CID006857712 | |
| Drug | m-toluidine | 5.82e-05 | 34 | 142 | 4 | CID000007934 | |
| Drug | Lyndiol | 5.82e-05 | 34 | 142 | 4 | CID000082149 | |
| Drug | YS980 | 6.49e-05 | 13 | 142 | 3 | CID000171857 | |
| Drug | 2,4,5-trichlorobenzoic acid | 6.53e-05 | 35 | 142 | 4 | CID000005786 | |
| Drug | dimethoxystrychnine | 6.53e-05 | 35 | 142 | 4 | CID000009649 | |
| Drug | Dixan | 6.53e-05 | 35 | 142 | 4 | CID000010404 | |
| Drug | Glutathione | 7.32e-05 | 36 | 142 | 4 | DB00143 | |
| Drug | pheophytin | 7.57e-05 | 284 | 142 | 9 | CID000000250 | |
| Drug | p-MeC | 8.22e-05 | 14 | 142 | 3 | CID000451929 | |
| Drug | ethoxyquin | 8.95e-05 | 116 | 142 | 6 | CID000003293 | |
| Drug | Eugenol | 9.79e-05 | 229 | 142 | 8 | ctd:D005054 | |
| Drug | stilbene oxide | 1.00e-04 | 74 | 142 | 5 | CID000028649 | |
| Drug | Goralatide | 1.02e-04 | 15 | 142 | 3 | CID000065938 | |
| Drug | anad | 1.02e-04 | 15 | 142 | 3 | CID005287574 | |
| Drug | procyanidin B-5 3,3'-di-O-gallate | 1.02e-04 | 15 | 142 | 3 | CID003086518 | |
| Drug | CoCl2 | 1.07e-04 | 75 | 142 | 5 | CID003015678 | |
| Drug | A0395 | 1.07e-04 | 75 | 142 | 5 | CID009906466 | |
| Drug | 2,4,6-trinitrotoluene | 1.07e-04 | 75 | 142 | 5 | CID000008376 | |
| Drug | Gsts | 1.09e-04 | 173 | 142 | 7 | CID000128079 | |
| Drug | BDP_X | 1.11e-04 | 40 | 142 | 4 | CID000978607 | |
| Drug | Ethoxyquin | 1.11e-04 | 40 | 142 | 4 | ctd:D005015 | |
| Drug | hexafluorenium | 1.15e-04 | 3 | 142 | 2 | CID000003601 | |
| Disease | Brugada syndrome (implicated_via_orthology) | 2.28e-09 | 5 | 138 | 4 | DOID:0050451 (implicated_via_orthology) | |
| Disease | metabolite measurement | ABCC1 MCPH1 SPC25 UNC93A ACE BABAM2 GSTM2 FRA10AC1 MYOF SYNE2 UGT2B15 UGT2B17 C4orf33 ENPEP SORL1 | 6.33e-08 | 560 | 138 | 15 | EFO_0004725 |
| Disease | hereditary spastic paraplegia 76 (implicated_via_orthology) | 9.94e-07 | 5 | 138 | 3 | DOID:0110821 (implicated_via_orthology) | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 1.74e-06 | 43 | 138 | 5 | DOID:2476 (implicated_via_orthology) | |
| Disease | breast cancer (is_implicated_in) | 7.08e-06 | 150 | 138 | 7 | DOID:1612 (is_implicated_in) | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 1.61e-05 | 11 | 138 | 3 | EFO_0801531 | |
| Disease | Drug-Induced Liver Disease | 2.16e-05 | 404 | 138 | 10 | C0860207 | |
| Disease | Chemical and Drug Induced Liver Injury | 2.16e-05 | 404 | 138 | 10 | C4277682 | |
| Disease | Drug-Induced Acute Liver Injury | 2.16e-05 | 404 | 138 | 10 | C3658290 | |
| Disease | Hepatitis, Toxic | 2.16e-05 | 404 | 138 | 10 | C0019193 | |
| Disease | Chemically-Induced Liver Toxicity | 2.16e-05 | 404 | 138 | 10 | C4279912 | |
| Disease | Hepatitis, Drug-Induced | 2.16e-05 | 404 | 138 | 10 | C1262760 | |
| Disease | level of glutathione S-transferase mu 1 in blood serum | 2.17e-05 | 2 | 138 | 2 | OBA_2041806 | |
| Disease | N-acetylgalactosamine measurement | 2.17e-05 | 2 | 138 | 2 | EFO_0800149 | |
| Disease | 3,7-dimethylurate measurement | 2.17e-05 | 2 | 138 | 2 | EFO_0800949 | |
| Disease | male infertility due to globozoospermia (implicated_via_orthology) | 2.17e-05 | 2 | 138 | 2 | DOID:0112312 (implicated_via_orthology) | |
| Disease | autosomal recessive nonsyndromic deafness 114 (implicated_via_orthology) | 2.17e-05 | 2 | 138 | 2 | DOID:0111642 (implicated_via_orthology) | |
| Disease | esophageal atresia (is_implicated_in) | 2.17e-05 | 2 | 138 | 2 | DOID:10485 (is_implicated_in) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 2.40e-05 | 36 | 138 | 4 | DOID:11723 (implicated_via_orthology) | |
| Disease | Neurodegenerative Disorders | 3.32e-05 | 39 | 138 | 4 | C0524851 | |
| Disease | Degenerative Diseases, Central Nervous System | 3.32e-05 | 39 | 138 | 4 | C0270715 | |
| Disease | Degenerative Diseases, Spinal Cord | 3.32e-05 | 39 | 138 | 4 | C0751733 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 3.51e-05 | 14 | 138 | 3 | DOID:10976 (biomarker_via_orthology) | |
| Disease | Parkinson Disease | 5.05e-05 | 85 | 138 | 5 | C0030567 | |
| Disease | focal segmental glomerulosclerosis | 5.36e-05 | 16 | 138 | 3 | EFO_0004236 | |
| Disease | focal adhesion kinase 1 measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0020393 | |
| Disease | versican core protein measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0803248 | |
| Disease | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0803220 | |
| Disease | U6 snRNA phosphodiesterase measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0803211 | |
| Disease | Alzheimer disease, diastolic blood pressure | 6.49e-05 | 3 | 138 | 2 | EFO_0006336, MONDO_0004975 | |
| Disease | phosphatidylinositol transfer protein alpha isoform measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0802862 | |
| Disease | orexigenic neuropeptide QRFP measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0802832 | |
| Disease | interleukin-17A measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0022026 | |
| Disease | thioredoxin domain-containing protein 11 measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0803147 | |
| Disease | nectin-2 measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0802788 | |
| Disease | myelin regulatory factor measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0802767 | |
| Disease | C-type lectin domain family 4 member M measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0020202 | |
| Disease | aurora kinase A measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0020168 | |
| Disease | rho guanine nucleotide exchange factor 7 measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0803020 | |
| Disease | inactive dipeptidyl peptidase 10 measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0802624 | |
| Disease | DCC-interacting protein 13-alpha measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0802455 | |
| Disease | g-protein coupled receptor 26 measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0802558 | |
| Disease | ES1 protein homolog, mitochondrial measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0802529 | |
| Disease | pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0801905 | |
| Disease | cyclin-dependent kinase 2-associated protein 1 measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0802440 | |
| Disease | roundabout homolog 3 measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0020714 | |
| Disease | beta-defensin 107 measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0802317 | |
| Disease | cholic acid glucuronide measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0800574 | |
| Disease | kinetochore protein NDC80 homolog measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0801748 | |
| Disease | glypican-2 measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0020414 | |
| Disease | protein transport protein Sec61 subunit gamma measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0802965 | |
| Disease | proteasome subunit beta type-5 measurement | 6.49e-05 | 3 | 138 | 2 | EFO_0802923 | |
| Disease | obesity (implicated_via_orthology) | 7.15e-05 | 215 | 138 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | diabetic retinopathy (is_implicated_in) | 8.93e-05 | 50 | 138 | 4 | DOID:8947 (is_implicated_in) | |
| Disease | COVID-19 (is_implicated_in) | 1.25e-04 | 21 | 138 | 3 | DOID:0080600 (is_implicated_in) | |
| Disease | dipeptidyl peptidase 1 measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0020325 | |
| Disease | X-25937 measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0800937 | |
| Disease | t-cell surface glycoprotein CD8 beta chain measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0803135 | |
| Disease | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0801374 | |
| Disease | magnesium transporter NIPA4 measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0802723 | |
| Disease | leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2 measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0802702 | |
| Disease | renal fibrosis (is_marker_for) | 1.29e-04 | 4 | 138 | 2 | DOID:0050855 (is_marker_for) | |
| Disease | casein kinase II subunit alpha measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0020238 | |
| Disease | ATP synthase subunit beta, mitochondrial measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0020166 | |
| Disease | sorting nexin-7 measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0803094 | |
| Disease | rho-related GTP-binding protein Rho6 measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0803022 | |
| Disease | N-acetylgalactosamine measurement, N-acetylglucosamine measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0800149, EFO_0801068 | |
| Disease | keratin, type II cytoskeletal 7 measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0802675 | |
| Disease | integrin alpha-5 measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0802637 | |
| Disease | Gaucher Disease | 1.29e-04 | 4 | 138 | 2 | C0017205 | |
| Disease | cold shock domain-containing protein C2 measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0802415 | |
| Disease | receptor tyrosine-protein kinase erbb-4 measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0020702 | |
| Disease | protein SERAC1 measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0801963 | |
| Disease | zinc finger protein 18 measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0802226 | |
| Disease | Meningococcal Infections | 1.29e-04 | 4 | 138 | 2 | C0025303 | |
| Disease | Gaucher Disease, Type 2 (disorder) | 1.29e-04 | 4 | 138 | 2 | C0268250 | |
| Disease | Gaucher Disease, Type 3 (disorder) | 1.29e-04 | 4 | 138 | 2 | C0268251 | |
| Disease | protocadherin beta-1 measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0802972 | |
| Disease | radiation-inducible immediate-early gene IEX-1 measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0802987 | |
| Disease | histone acetyltransferase type b catalytic subunit measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0020452 | |
| Disease | factor VII activating protease measurement | 1.30e-04 | 55 | 138 | 4 | EFO_0009368 | |
| Disease | nephrosis (biomarker_via_orthology) | 1.44e-04 | 22 | 138 | 3 | DOID:2527 (biomarker_via_orthology) | |
| Disease | zinc transporter 3 measurement | 2.15e-04 | 5 | 138 | 2 | EFO_0803287 | |
| Disease | dual specificity protein kinase CLK2 measurement | 2.15e-04 | 5 | 138 | 2 | EFO_0801548 | |
| Disease | poly(U)-specific endoribonuclease measurement | 2.15e-04 | 5 | 138 | 2 | EFO_0802879 | |
| Disease | potassium voltage-gated channel subfamily A member 10 measurement | 2.15e-04 | 5 | 138 | 2 | EFO_0802888 | |
| Disease | dual specificity tyrosine-phosphorylation-regulated kinase 3 measurement | 2.15e-04 | 5 | 138 | 2 | EFO_0020337 | |
| Disease | tuftelin-interacting protein 11 measurement | 2.15e-04 | 5 | 138 | 2 | EFO_0803199 | |
| Disease | tetratricopeptide repeat protein 17 measurement | 2.15e-04 | 5 | 138 | 2 | EFO_0803144 | |
| Disease | cellular tumor antigen p53 measurement | 2.15e-04 | 5 | 138 | 2 | EFO_0022006 | |
| Disease | tight junction protein ZO-1 measurement | 2.15e-04 | 5 | 138 | 2 | EFO_0803155 | |
| Disease | augurin measurement | 2.15e-04 | 5 | 138 | 2 | EFO_0801399 | |
| Disease | chymotrypsin-like protease CTRL-1 measurement | 2.15e-04 | 5 | 138 | 2 | EFO_0801476 | |
| Disease | hephaestin-like protein 1 measurement | 2.15e-04 | 5 | 138 | 2 | EFO_0802597 | |
| Disease | Gaucher Disease, Type 1 | 2.15e-04 | 5 | 138 | 2 | C1961835 | |
| Disease | histone-lysine N-methyltransferase SETD2 measurement | 2.15e-04 | 5 | 138 | 2 | EFO_0802604 | |
| Disease | C-type lectin domain family 4 member D measurement | 2.15e-04 | 5 | 138 | 2 | EFO_0802347 | |
| Disease | tumor necrosis factor ligand superfamily member 15 measurement | 2.15e-04 | 5 | 138 | 2 | EFO_0020794 | |
| Disease | adenylyltransferase and sulfurtransferase MOCS3 measurement | 2.15e-04 | 5 | 138 | 2 | EFO_0802257 | |
| Disease | a disintegrin and metalloproteinase with thrombospondin motifs 3 measurement | 2.15e-04 | 5 | 138 | 2 | EFO_0802245 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KDWVFFQSFIGDLKQ | 106 | P60509 | |
| LEFTKKFSEWGNNAF | 431 | P06276 | |
| KKLALFDEWNSLAVY | 156 | Q8WYN0 | |
| FKSFNFNTLLGEEWK | 171 | Q8N1A6 | |
| QFKQVFKELEFLGWY | 111 | Q7L5N1 | |
| EYFLKWKGFTDADNT | 46 | Q13185 | |
| AKYWLKGFVAFQAAI | 81 | Q8WWZ4 | |
| QEFAEAWGQKAKELY | 91 | P12821 | |
| NNRKGKLIFFYEWSV | 71 | O95433 | |
| KYFWNDTIHNFDFLK | 146 | Q9H7F0 | |
| WFAKKITQDYGQDAA | 191 | P15085 | |
| GKYFLWEEKFNSLNE | 116 | Q13588 | |
| WEEKFNSLNELVDFY | 121 | Q13588 | |
| EKIDWEFKNELYFLS | 881 | Q8N139 | |
| FGSWTYDKAKIDLEQ | 201 | Q15822 | |
| SKTYFNLAVDEKGLW | 421 | Q6ZMI3 | |
| DGSVNFFRNWENYKK | 326 | O95841 | |
| EQGNEFWSALLEKAY | 171 | A6NHC0 | |
| FWSALLEKAYAKLNG | 176 | A6NHC0 | |
| NDFTWFKLNDTLDYE | 521 | P08603 | |
| FWSALLEKAYAKVNG | 186 | P07384 | |
| LWKFVDDQLDYLFAK | 1131 | Q9UKL3 | |
| NLFWGALLEKAYAKL | 171 | A8MX76 | |
| FDRDLIFLFKGNQYW | 336 | P22894 | |
| QEWTFTLYDFDNNGK | 136 | Q969G9 | |
| DILKDHWQKYGRNFF | 411 | P36871 | |
| WFLDQFRKTYVGDQL | 551 | Q9H2T7 | |
| AKSNYNFEKPFLWLA | 151 | P62826 | |
| VQKEGKISYADFVWF | 366 | Q9Y5P8 | |
| EFSELELQEWYKGFL | 21 | P84074 | |
| KGEYFWLEPKNAFEN | 211 | Q9UHI5 | |
| WNDETLYQEFNGLKK | 71 | Q13231 | |
| GRDYWKFDNQKLSVE | 541 | Q9Y5R2 | |
| NFSDFLFRWYLEKGK | 896 | Q8WUM0 | |
| KYNDTFWKEFGTNIK | 136 | Q58FF3 | |
| KKIYWVNESAGFLFA | 2676 | Q86XX4 | |
| EFSEQELKQWYKGFL | 21 | Q9UM19 | |
| IFKDGYQSTWDKAQK | 51 | Q8NEM0 | |
| YDRSQWLNEKFKLGL | 41 | P46439 | |
| YKSSWENQKAKGFEL | 786 | Q86VF7 | |
| QNKAWFREGFNEKYL | 246 | Q92485 | |
| WNLDELPKFEKNFYQ | 46 | P17844 | |
| LGTWKLVDSKNFDDY | 6 | P05413 | |
| EKQIDYKSFFSALNW | 686 | Q5JST6 | |
| ADLSKYKENKFGFRW | 146 | Q70Z53 | |
| LEFAVYTFNKQSKDW | 51 | Q5W188 | |
| YDRSQWLNEKFKLGL | 41 | P28161 | |
| TLLKKWALYSFNDGE | 1806 | Q5S007 | |
| EKNSWKLFQFDFTGV | 236 | P78334 | |
| LEKYQFKNAKTSDFW | 506 | Q07075 | |
| DQYSETLLKKWAGIF | 431 | Q9Y2D4 | |
| GKEAKLYLFQAQEWL | 66 | Q86V85 | |
| GKYFLWVVKFNSLNE | 116 | P62993 | |
| QEYESFFEGWDATKK | 896 | Q92729 | |
| GNTDYDWKTFEKNAR | 911 | Q9UII4 | |
| EKFKLLFQSYNVNDW | 326 | Q13772 | |
| ADDKYNDTFWKEFGT | 476 | P14625 | |
| GDYFEKALQWVLKQN | 2146 | Q8NCM8 | |
| VLSFKGYWEKLNSNL | 516 | A4D1B5 | |
| GFYDRNKLFWKEIQD | 2191 | Q9C0G6 | |
| ILGAFFYWRSKNKEE | 261 | Q5DX21 | |
| QTWKNEGFFALYKGF | 251 | Q5SVS4 | |
| RKNFLNENFDYKIWD | 991 | Q8N1I0 | |
| EIYAGKKNNWTGEFS | 156 | Q9NXR7 | |
| KLDKYELAVDGFNWE | 316 | Q9NY28 | |
| TGKLGFEEFKYLWNN | 136 | Q96L46 | |
| TGKLGFEEFKYLWNN | 156 | P04632 | |
| QFFLAKEGKWLNEYK | 311 | Q8TDW7 | |
| NFYEASDWFKEALQI | 546 | Q6PD62 | |
| VEYLLKWKGFSDEDN | 36 | P83916 | |
| NYFEPLFTWLKDQNK | 586 | Q9BYF1 | |
| DKGQQYRNWFLKEFP | 131 | O14791 | |
| DNLDFIQWFKKFYDA | 146 | Q15555 | |
| DADYKQWRKDAGFLS | 746 | Q9UHC6 | |
| LVNAIYFKGNWKDKF | 161 | P30740 | |
| KYVAFFLEEVSGWQK | 1486 | Q9NYC9 | |
| SFWIDQKKGFDELEF | 541 | Q9BRP7 | |
| NEFWSALLEKAYAKL | 166 | O14815 | |
| FWSALLEKAYAKING | 176 | P17655 | |
| KLKWAFNLYDINKDG | 166 | Q9Y2W7 | |
| WGIFDALSQKKYEQE | 2646 | Q92736 | |
| QWSQFKGYFIFKLEK | 41 | Q9NY27 | |
| KFVNDTKAPDWQGYF | 351 | P33527 | |
| KGNLEKLQSYWEVGF | 466 | Q99683 | |
| LKKATGDWFYDQKVN | 111 | Q96C24 | |
| DFKGLLLSDYKFSWD | 436 | Q5T160 | |
| DWKELFFNAKPIYEQ | 461 | Q9C093 | |
| TLWVAFAKFYEDNGQ | 396 | Q9HCS7 | |
| LYWVDAGFKKIEVAN | 846 | Q92673 | |
| LETYEGWKLEKQDSF | 301 | Q9UGK8 | |
| FSQEELLKIWKGLFY | 46 | Q14684 | |
| EKWGEEEAELNKNFY | 481 | P49589 | |
| LKKVFDYIGLNWDFS | 3001 | Q8WXH0 | |
| VDKNKANRESLYDFW | 176 | Q6UX01 | |
| FAELLSYWQFVGKDK | 901 | Q7Z494 | |
| GKTNQKLEWAFSLYD | 96 | P35243 | |
| WKKAQFIFELLGEYS | 501 | Q587J7 | |
| YDRSQWLNEKFKLGL | 41 | Q03013 | |
| YDRSQWLNEKFKLGL | 41 | P09488 | |
| NWFKNFLGYKESVHL | 516 | Q96ST3 | |
| FQDDVFNEKGWNYIL | 91 | P43490 | |
| FKDSQYWRFTNDIKD | 1211 | Q92954 | |
| EENWKFEKNNEYGDT | 256 | Q14849 | |
| LALFDKSINEFWNKF | 6 | Q9HBM1 | |
| GKNESEYTVKWQDFF | 101 | P78536 | |
| IKLKNWEEGGYFNTD | 506 | O95573 | |
| LRWGVFDEYNNDEKF | 161 | A8K7I4 | |
| KTKEGWDFHSQFILY | 981 | Q96JI7 | |
| EVINEYSWKVDFLKG | 56 | Q9NZ43 | |
| YLSEKQFFAEEWQRK | 496 | O60296 | |
| GIFEDLQNYILEKKW | 126 | Q9H1E5 | |
| FSDEKYQKGISLWAI | 241 | Q8N609 | |
| EFNEHELKQWYKGFL | 21 | P62760 | |
| FKGNKYWVFKDTTLQ | 406 | P51512 | |
| YLSNNFGWKEAEADK | 316 | Q8NCC5 | |
| KDFVKYWDNVEAFQA | 21 | P49888 | |
| AELDYRKAFGNEWKQ | 381 | Q15813 | |
| ALYFSDFWNKLDVGA | 861 | O94759 | |
| WFSYEGAELEKTFIK | 446 | A6NH21 | |
| EDFAIDLNGKKYAWQ | 631 | Q9H0D6 | |
| FEKSKEAAFANYRLW | 376 | Q86WB7 | |
| FIWDKTDVYNQKVFG | 1116 | Q6N022 | |
| GDEEEYWNSSKFKAF | 6 | Q9H9C1 | |
| YEAEKVWLAQKDGFT | 511 | Q8IUG5 | |
| LAFVFKDWIKDQLYF | 111 | P62079 | |
| FWNFYSKLKQNPREE | 771 | O43149 | |
| GYVVIKFNKDSWDLQ | 136 | Q5TAH2 | |
| KLLQAVAKYGEQDWF | 411 | Q5SXM2 | |
| FKIWVIFNFLSEDKY | 116 | Q9UH65 | |
| DKVYWQRQDDGSFKI | 501 | P22735 | |
| QLAKDLAWLYFEIFD | 66 | Q9NVR7 | |
| NKWYLFNDAEVKPFD | 2181 | Q70CQ2 | |
| FDFWFQIYDLKKWDQ | 221 | P54855 | |
| FDIKDGKLLWEQELY | 81 | O00401 | |
| KHFLEAIENNKYGWF | 181 | Q8WU90 | |
| RKKLGEFFQTKYDWD | 711 | Q15029 | |
| YKESQDKFLWQAAFI | 96 | Q2M3X9 | |
| VGDYDDELKQFWNKS | 401 | Q92547 | |
| ELLKSYWLDNFAKDS | 366 | Q6NUK1 | |
| SEGEKVNYEKFRNWL | 136 | Q8NFA0 | |
| FDFWFQAYDLKKWDQ | 221 | O75795 | |
| QDLEFQWKDGEINYK | 96 | Q6ZNA1 | |
| EWFANNYKKFGATLE | 376 | P62495 | |
| EKFEGNLKSQYFWRP | 806 | Q8NEV4 | |
| QIWDNDKFSLDDYLG | 1886 | Q9NZM1 |